Top Global Pharmaceutical Leader Selects I-many's ContractSphere(R) Solution

PHILADELPHIA, PA--(Marketwire - March 12, 2010) -

Highlighted Links

I-many

I-many, Inc., the leading provider of Contract Management and Revenue Optimization software, announced today a top 25 pharmaceutical company has selected I-many ContractSphere® solutions as a key enabling technology for its next generation contracting system that will meet the evolving business and regulatory requirements and scale to manage rapidly growing future volumes of contractual data. The selection of ContractSphere® solutions reflects I-many's ability to deliver the industry's leading and most comprehensive contracting solution.

After an extensive evaluation of other contract management offerings, this top 25 global pharmaceutical company selected I-many's ContractSphere® Contract Manager, CARS®, I-many Validata® and Business Intelligence (BI) solutions to author and manage contractual agreements across all departments within the enterprise, including commercial operations, legal, clinical, and IT. I-many's solutions met key requirements for commercial contracting validation; prescription level data validation; adjudication; reporting; seamless integration between contract authoring and transaction adjudication; and integration of government contracting operations within a robust and scalable enterprise-class platform.

"I-many continues to be the standard for contract management and revenue optimization at leading pharmaceutical companies," said P. Kevin Kilroy, President and CEO of I-many. "This recent success is a testament to the continued value we provide to hundreds of customers in a wide variety of industries. Driven by the dedicated team of business and technology professionals focused on developing innovative solutions for optimizing contract processes and performance, and ensuring transaction compliance; I-many is the leading provider of contract management software and services for ten of the top ten pharmaceutical companies."

In a recent IDC Health Insights report entitled "Revenue Leakage - Pharma's $11 Billion Problem" (Document # HI220793, Dec. 2009), it was found that revenue leakage causes pharmaceutical companies to lose approximately 4.4% of overall revenue on an annual basis.

I-many's comprehensive solutions enable organizations to manage the entire contract lifecycle, from pre-contract processes and contract management to active compliance, contract optimization, demand channel visibility and control; resulting in greater levels of insight into contract performance, improved profitability, measurable return on investments and the ability to contain the current and potential issues that are identified in the report.

About I-many®

I-many is the leading provider of contract management and revenue optimization software and services for the enterprise within the life sciences industry as well as other sectors that must manage complex contractual relationships integral to their core business. With 21 of the top 25 life sciences companies and hundreds of organizations across 21 industries worldwide, I-many enables businesses to manage the entire contract lifecycle, from pre-contract processes and contract management to active compliance, contract optimization, demand channel visibility and control. The result is an end-to-end solution that provides greater levels of insight into contract performance and regulatory compliance, allowing companies to improve profitability and achieve a significant measurable return on investment within a very short timeframe. For more information, please visit www.imany.com.